Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Dausset

Showing results (301-310 of 396) with videos related to

Pageof 40
Sort By:
Transplantation Proceedings|December 1, 1974
HL-A antigens and idiopathic autoimmune hemolytic anemiasJ P Clauvel, A Marcelli-Barge, I Gautier Coggia, et al.
Journees Annuelles De Diabetologie De L'Hotel-Dieu|January 1, 1977
[Insulin-dependent diabetes and HLA]J Dausset, J Hors, L Contu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1979
Human T cell differentiation antigens and correlation of their expression with various markers of T cell maturationL Boumsell, A Bernard, H Coppin, et al.
Lancet (London, England)|December 24, 1998
Fetal DNA in skin of polymorphic eruptions of pregnancyS Aractingi, N Berkane, P Bertheau, et al.
Transplantation Proceedings|December 1, 1973
Cell-mediated lympholysis (CML) in the absence of LD2 mixed lymphocyte reaction and CML in the presence of SD1-SD2 identity in two HL-S-genotyped familiesC Mawas, M Sasportes, Y Christen, et al.
Diabete & Metabolisme|December 1, 1979
Insulin-dependent diabetes and HLAJ Dausset, J Hors, L Contu, et al.
Immunogenetics|January 1, 1986
Correlation between an HLA-DQ alpha length polymorphism of messenger RNA and serologically defined specificities (DQw1, DRw53, DR3+5)P Loiseau, P Lehn, F Dautry, et al.
Immunogenetics|January 1, 1985
Association of class II HLA-DQ beta chain DNA restriction fragments with multiple sclerosisA Marcadet, C Massart, G Semana, et al.
Seminars in Cancer Biology|March 27, 1999
HLA-G expression: immune privilege for tumour cells?F A Cabestre, S Lefebvre, P Moreau, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 15, 1992
Altered binding of regulatory factors to HLA class I enhancer sequence in human tumor cell lines lacking class I antigen expressionO Blanchet, J F Bourge, H Zinszner, et al.
Pageof 40

Showing results (301-310 of 396) with videos related to

Sort By:
Pageof 40
Transplantation Proceedings|December 1, 1974
HL-A antigens and idiopathic autoimmune hemolytic anemiasJ P Clauvel, A Marcelli-Barge, I Gautier Coggia, et al.
Journees Annuelles De Diabetologie De L'Hotel-Dieu|January 1, 1977
[Insulin-dependent diabetes and HLA]J Dausset, J Hors, L Contu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1979
Human T cell differentiation antigens and correlation of their expression with various markers of T cell maturationL Boumsell, A Bernard, H Coppin, et al.
Lancet (London, England)|December 24, 1998
Fetal DNA in skin of polymorphic eruptions of pregnancyS Aractingi, N Berkane, P Bertheau, et al.
Transplantation Proceedings|December 1, 1973
Cell-mediated lympholysis (CML) in the absence of LD2 mixed lymphocyte reaction and CML in the presence of SD1-SD2 identity in two HL-S-genotyped familiesC Mawas, M Sasportes, Y Christen, et al.
Diabete & Metabolisme|December 1, 1979
Insulin-dependent diabetes and HLAJ Dausset, J Hors, L Contu, et al.
Immunogenetics|January 1, 1986
Correlation between an HLA-DQ alpha length polymorphism of messenger RNA and serologically defined specificities (DQw1, DRw53, DR3+5)P Loiseau, P Lehn, F Dautry, et al.
Immunogenetics|January 1, 1985
Association of class II HLA-DQ beta chain DNA restriction fragments with multiple sclerosisA Marcadet, C Massart, G Semana, et al.
Seminars in Cancer Biology|March 27, 1999
HLA-G expression: immune privilege for tumour cells?F A Cabestre, S Lefebvre, P Moreau, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 15, 1992
Altered binding of regulatory factors to HLA class I enhancer sequence in human tumor cell lines lacking class I antigen expressionO Blanchet, J F Bourge, H Zinszner, et al.
Pageof 40